Allogene Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of ALLO for the last quarter is 22.00 k USD, and it's 4.76% higher compared to the previous quarter. The net income of Q1 24 is -65.00 M USD.